{"id":15815,"date":"2012-06-20T00:00:00","date_gmt":"2012-06-19T22:00:00","guid":{"rendered":"http:\/\/www.bio-based.eu\/news\/index.php?startid=20120620-02n"},"modified":"2012-06-20T00:00:00","modified_gmt":"2012-06-19T22:00:00","slug":"cannabis-catch-all","status":"publish","type":"post","link":"https:\/\/renewable-carbon.eu\/news\/cannabis-catch-all\/","title":{"rendered":"Cannabis Catch-All?"},"content":{"rendered":"<p><b>GW Pharmaceuticals\u2014the United Kingdom\u2019s only legal cannabis production facility\u2014i<img SRC=\"https:\/\/renewable-carbon.eu\/news\/wp-content\/uploads\/news-images\/20120620-02\/marijuana.jpg\" align=\"right\" style=\"margin-left:10px;\" BORDER=\"0\" ALT=\"marijuana.jpg\"\/>s already developing Sativex, a drug consisting of two principal cannabinoids (THC and CBD). Sativex is currently in Phase III trials for treating muscle spasticity in multiple sclerosis patients. But GW\u2019s researchers are also studying how marijuana derivatives could be used to treat a much wider range of diseases, including metabolic disorders, epilepsy, ulcerative colitis, psychosis, brain injury, and cancer pain.<\/b><\/p>\n<p>&#8220;As rigorous modern research with cannabinoids comes to fruition, a new era of treatment options may have arrived,\u201d David Potter, director of Botanical Research and Cultivation at GW Pharmaceuticals who wrote about the company\u2019s efforts this month in The Biologist, said in a press release.<\/p>\n<p><i>&#8230;Full Text: <a href=\"http:\/\/the-scientist.com\/2012\/06\/20\/cannabis-catch-all\/\" >http:\/\/the-scientist.com\/2012\/06\/20\/cannabis-catch-all\/<\/a><\/p>\n<p>Tags: THC, THCV, alternative medicines, non-traditional treatments<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p><b>GW Pharmaceuticals&mdash;the United Kingdom&rsquo;s only legal cannabis production facility&mdash;is already developing Sativex, a drug consisting of two principal cannabinoids (THC and CBD). Sativex is currently<\/b><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","nova_meta_subtitle":"","footnotes":""},"categories":[5572],"tags":[],"supplier":[1250],"class_list":["post-15815","post","type-post","status-publish","format-standard","hentry","category-bio-based","supplier-gw-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/15815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/comments?post=15815"}],"version-history":[{"count":0,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/15815\/revisions"}],"wp:attachment":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/media?parent=15815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/categories?post=15815"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/tags?post=15815"},{"taxonomy":"supplier","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/supplier?post=15815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}